Cirrhosis or highly advanced fibrosis is the 13th leading cause of death in the U.S. The leading cause of cirrhosis is the hepatitis C virus infection which affects more than 4 million Americans. Males with hepatitis C infection are much more likely to develop cirrhosis (up to one-third after several decades of infection) compared to females. However, there are unexplained inter-individual differences in risk as most HCV-infected males do not develop cirrhosis even after accounting for other risk factors like alcohol use. One potential explanatory factor may be genetic variation in the male sex hormone or androgen receptor (AR) gene. It regulates or co-regulates many other diverse genes, many with likely important roles in liver disease risk including controlling cellular inflammation and DNA repair. Experimental data suggests the AR and also its androgen ligands including the primary male sex hormone testosterone may play a role in increasing risk of liver cancer due to another viral infection, Hepatitis B virus. Our group recently demonstrated that increased testosterone levels were associated with significantly increased risk of advanced liver disease based on results of blood tests in male veterans with chronic hepatitis C infection. We will use an age-matched case-control study performed in 200 Caucasian male veterans with chronic HCV to evaluate the association between the androgen mediated AR signaling pathway spanning from germline genotype to hepatic gene expression and the risk of cirrhosis in male veterans with chronic hepatitis C infection. We hypothesize that changes in genotype or endophenotype associated with enhanced AR pathway signaling will be associated with increased risk of advanced fibrosis. The two specific aims of our proposal are:
Specific Aim 1 : To determine if germline variations in the AR gene and in key functionally-related genes in the androgen-mediated androgen receptor (AR) signaling pathway (e.g., 5?-reductase 2 (SRD5A2)) are associated with risk of advanced biopsy-determined hepatic fibrosis in Caucasian males with chronic hepatitis C infection.
Specific Aim 2 : To determine if variation in hepatic AR gene expression or in related AR signaling pathway genes is associated with risk of biopsy-confirmed advanced hepatic fibrosis in Caucasian males with chronic hepatitis C infection. This study has the potential to expand our understanding of the etiology of advanced liver fibrosis in males in the background of hepatitis C infection, with implications for screening and targeted therapies. It will also extend my NIDDK-sponsored K01 research and training in genetic epidemiology of chronic digestive and liver diseases, and also provide foundational data needed to support an R01 application I plan to submit in K01 Year 5 to more fully examine these hypotheses.

Public Health Relevance

Hepatitis C viral infection greatly increases risk of developing cirrhosis and liver cancer. Males are also at increased risk of both conditions. This proposal aims at examining the association between novel genetic risk factors related to the action of male sex hormones and risk of cirrhosis in hepatitis C-infected males.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Small Research Grants (R03)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
White, Donna L; Thrift, Aaron P; Kanwal, Fasiha et al. (2017) Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. Gastroenterology 152:812-820.e5
Natarajan, Yamini; White, Donna L; El-Serag, Hashem B et al. (2017) Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV. Dig Dis Sci 62:76-83
Kanwal, Fasiha; Kramer, Jennifer R; El-Serag, Hashem B et al. (2016) Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus. Clin Infect Dis 63:291-9
Khan, Anam; Tansel, Aylin; White, Donna L et al. (2016) Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review. Clin Gastroenterol Hepatol 14:191-202.e1-4; quiz e20
Erickson, Megan; Braun, Katie; List, Riesa et al. (2016) Evaluation of US Veterans Nutrition Education for Diabetes Prevention. J Nutr Educ Behav 48:538-543.e1
Sever, Sakine; White, Donna L; Garcia, José M (2016) Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review. Endocr Relat Cancer 23:R393-409
Mody, Avni; White, Donna; Kanwal, Fasiha et al. (2015) Relevance of low testosterone to non-alcoholic fatty liver disease. Cardiovasc Endocrinol 4:83-89
Kanwal, Fasiha; White, Donna L; Jiao, Li et al. (2015) Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection. Dig Dis Sci 60:2030-7
Khalaf, Natalia; White, Donna; Kanwal, Fasiha et al. (2015) Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. Clin Gastroenterol Hepatol 13:1521-31.e3
Duan, Zhigang; Chen, Guoqing; Chen, Liang et al. (2014) Determinants of concentrations of N(?)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancer. Int J Mol Epidemiol Genet 5:152-63

Showing the most recent 10 out of 15 publications